All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis

American Journal of Roentgenology

Volumn 204, Issue 4, 2015, Pages 898-902

  Engel, Jessica M ^a   Stankowski Drengler, Trista J ^a   Stankowski, Rachel V ^a   Liang, Hong ^a   Doi, Suhail A ^b   Onitilo, Adedayo A ^a,b  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Breast cancer; Mammography; Mortality

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CAUSAL ATTRIBUTION; COMORBIDITY; FAMILY HISTORY; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURVIVAL TIME; WOMEN'S HEALTH; BREAST TUMOR; CAUSE OF DEATH; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; RADIOGRAPHY; SURVIVAL; UNITED STATES; UTILIZATION;

AGED; BREAST NEOPLASMS; CAUSE OF DEATH; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; WISCONSIN;

EID: 84929650570     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.14.12666     Document Type: Article

References (47)

1. American Cancer Society. Cancer facts & fgures 2013. Atlanta, GA: American Cancer Society, 2013
2. Shapiro S. Screening: assessment of current studies. Cancer 1994; 74:231-238
3. Tabár L, Vitak B, Chen HH, et al. Swedish Two-County Trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011; 260:658-663
4. Nickson C, Mason KE, English DR, Kavanagh AM. Mammographic screening and breast cancer mortality: a case-control study and meta-analysis. Cancer Epidemiol Biomarkers Prev 2012; 21: 1479-1488
5. Nagtegaal ID, Duffy SW. Reduction in rate of node metastases with breast screening: consistency of association with tumor size. Breast Cancer Res Treat 2013; 137:653-663
6. Klemi PJ, Parvinen I, Pylkkanen L, et al. Signif-cant improvement in breast cancer survival through population-based mammography screening. Breast 2003; 12:308-313
7. McCann J, Duffy S, Day N; East Anglia Breast Screening Programme. Predicted long-term mortality reduction associated with the second round of breast screening in East Anglia. Br J Cancer 2001; 84:423-428
8. Fracheboud J, Otto SJ, van Dijck JA, et al. Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 2004; 91:861-867
9. Jensena AR, Ewertz M, Cold S, Storm HH, Over-gaard J. Time trends and regional differences in registration, stage distribution, surgical management, and survival of breast cancer in Denmark. Eur J Cancer 2003; 39:1783-1793
10. Malmgren JA, Parikh J, Atwood MK, Kaplan HG. Impact of mammography detection on course of breast cancer in women aged 40-49 years. Radiology 2012; 262:797-806
11. Kaplan HG, Malmgren JA. Disease-specifc survival in patient-detected breast cancer. Clin Breast Cancer 2006; 7:133-140
12. Jørgensen KJ, Keen JD, Gøtzsche PC. Is mammo-graphic screening justifable considering its substantial overdiagnosis rate and minor effect on mortality? Radiology 2011; 260:621-627
13. Welch HG, Frankel BA. Likelihood that a women with screen-detected breast cancer has had her "life saved" by that screening. Arch Intern Med 2011; 171:2043-2046
14. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009; 302:1685-1692
15. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012; 367:1998-2005
16. Bond M, Pavey T, Welch K, et al. Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess 2013; 17:1-170, v-vi
17. de Gelder R, Draisma G, Heijnsdijk EA, de Kon-ing HJ. Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths. Br J Cancer 2011; 104:1214-1220
18. Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifable? Lancet 2000; 355:129-134
19. Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 2002; 94:167-173
20. Marmot MG. Sorting through the arguments on breast screening. JAMA 2013; 309:2553-25549
21. Wilt TJ, Partin MR. Screening: simple messages-sometimes. Arch Intern Med 2011; 171:2046-2048
22. Penston J. Should we use total mortality rather than cancer specifc mortality to judge cancer screening programmes? Yes. BMJ 2011; 343:d6395
23. Tabár L, Duffy SW, Yen MF, et al. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. J Med Screen 2002; 9:159-162
24. Onitilo AA, Engel JM, Liang H, et al. Mammogra-phy utilization: patient characteristics and breast cancer stage at diagnosis. AJR 2013; 201:1057-1063
25. World Health Organization. International statistical classifcation of diseases and related health problems, 9th revision. Geneva, Switzerland: World Health Organization, 2010
26. Quan H, Sundararaja V, Halfon P, et al. Coding algorithms for defning comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43:1130-1139
27. Webb ML, Cady B, Michaelson JS, et al. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Cancer 2014; 120:2839-2846
28. Moss SM, Nystrom L, Jonsson H, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med Screen 2012; 19:26-32
29. Broeders M, Moss S, Nystrom L, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 2012; 19:14-25
30. Njor S, Nystrom L, Moss S, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of incidence-based mortality studies. J Med Screen 2012; 19:33-41
31. Duffy SW. Interpretation of the breast screening trials: a commentary on the recent paper by Gøtzsche and Olsen. Breast 2001; 10:209-212
32. Duffy SW, Tabar L, Smith RA. Screening for breast cancer with mammography. Lancet 2001; 358: 2166
33. de Koning HJ. Assessment of nationwide cancer-screening programmes. Lancet 2000; 355:80-81
34. Nyström L. Screening mammography re-evaluated. Lancet 2000; 355:748-749
35. Hayes C, Fitzpatrick P, Daly L, Buttimer J. Screening mammography re-evaluated. Lancet 2000; 355:749
36. Moss S, Blanks R, Quinn MJ. Screening mam-mography re-evaluated. Lancet 2000; 355:748
37. Duffy SW, Tabar L, Vitak B, et al. The Swedish Two-County Trial of mammographic screening: cluster randomization and end point evaluation. Ann Oncol 2003; 14:1196-1198
38. Freedman DA, Petitti DB, Robins JM. On the ef-fcacy of screening for breast cancer. Int J Epidemiol 2004; 33:43-55
39. Gail MH, Katki HA. Re: All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 2002; 94:862
40. Domingo L, Blanch J, Servitja S, et al. Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers. Eur J Cancer Prev 2013; 22:21-28
41. Carter TI, Reilly JJ. Missed opportunities: clinical antecedents in the diagnosis of advanced breast cancer. Ann Surg Oncol 2012; 19:2782-2785
42. Kremer ME, Downs-Holmes C, Novak RD, et al. Neglecting to screen women between the ages of 40 and 49 years with mammography: what is the impact on breast cancer diagnosis? AJR 2012; 198:1218-1222
43. National Comprehensive Cancer Network (NCCN) website. NCCN clinical practice guidelines in oncology: breast cancer, version 3. www. nccn.org/professionals/physician-gls/pdf/breast. pdf. Published 2013. Accessed November 5, 2013
44. American Cancer Society. Breast cancer. Atlanta, GA: American Cancer Society, 2013
45. Roychoudhuri R, Evans H, Robinson D, Moller H. Radiation-induces malignancies following radiotherapy for breast cancer. Br J Cancer 2004; 91:868-872
46. Clarke M, Collins R, Darby S, et al.; Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of randomized trials. Lancet 2005; 366:2087-2106
47. Steele RJ, Brewster DH. Should we use total mortality rather than cancer specifc mortality to judge cancer screening programmes? No. BMJ 2011; 343:d6397